Platform that helps patients find expert care options and access clinical trials and experimental treatments; based in Amsterdam.
MyTomorrows occupies a niche position in the healthtech sector by bridging the gap between clinical trial recruitment and 'expanded access' (compassionate use) programs for patients with unmet medical needs.
Market Share: As a private company, specific market share data is not publicly disclosed, but it is recognized as a key player in the European and international expanded access landscape.
The clinical trial recruitment and patient access market is highly fragmented, with platforms ranging from automated recruitment tools to high-touch patient advocacy services. The industry is moving toward more patient-centric models that prioritize transparency and ease of access.
A digital patient engagement company that focuses on connecting patients with clinical trials through a large network of partners.
Strengths
Weaknesses
Provides a global platform for patient recruitment and retention in clinical trials, emphasizing data-driven matching.
Strengths
Weaknesses
A patient-centric platform that simplifies the process of finding and enrolling in clinical trials.
Strengths
Weaknesses
Focuses specifically on the rare disease community to facilitate research and clinical trial participation.
Strengths
Weaknesses
Strong relationships with pharmaceutical companies for access programs
Expertise in navigating complex regulatory requirements for experimental treatments
Patient-first approach that addresses emotional and informational needs
Increasing regulatory scrutiny on patient recruitment practices
Competition from large-scale clinical research organizations (CROs) developing in-house patient matching tools
Dependency on pharmaceutical company partnerships for access to experimental drugs
Practice for MyTomorrows with an AI Agent
Uses this company profile to tailor behavioral, role, and culture questions